Blue Trust Inc
BEAM icon

Blue Trust Inc’s Beam Therapeutics BEAM Stock Holding History

Blue Trust Inc’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9
Closed -$218 – 2549
2025
Q3 		$218 Hold
9
– – ﹤0.01% 2510
2025
Q2 		$153 Sell
9
-407
-98% -$7.09K ﹤0.01% 2397
2025
Q1 		$8.13K Buy
416
+18
+5% +$472 ﹤0.01% 1985
2024
Q4 		$9.87K Sell
398
-2,737
-87% -$69.9K ﹤0.01% 1893
2024
Q3 		$73.5K Buy
3,135
+1,431
+84% +$37K ﹤0.01% 1391
2024
Q2 		$56.3K Buy
1,704
+1,642
+2,648% +$40.3K ﹤0.01% 1206
2024
Q1 		$2.05K Sell
62
-416
-87% -$13K ﹤0.01% 1823
2023
Q4 		$11K Buy
+478
New +$11.9K ﹤0.01% 1534
2023
Q3 		– Sell
-4
Closed – – 2039
2023
Q2 		$0 Sell
4
-1
-20% -$32 ﹤0.01% 2034
2023
Q1 		$0 Sell
5
-574
-99% -$22.7K ﹤0.01% 2307
2022
Q4 		$28K Buy
579
+499
+624% +$22.4K ﹤0.01% 1153
2022
Q3 		$3K Buy
80
+54
+208% +$3.08K ﹤0.01% 1665
2022
Q2 		$1K Buy
+26
New +$1.03K ﹤0.01% 1744

Other funds holding BEAM

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Blue Trust Inc's BEAM Position: Q4 2025 in Review

Blue Trust Inc sold out of Beam Therapeutics (BEAM) in Q4 2025, closing a stake of 9 shares — an estimated $218 sold.

Blue Trust Inc first reported a position in BEAM in Q2 2022 and held it in 13 quarters. The position peaked at $73.5K in Q3 2024. 247 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.

  • Blue Trust Inc reported no remaining Beam Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Blue Trust Inc sold 9 Beam Therapeutics shares in Q4 2025, an estimated $218.
  • Blue Trust Inc first reported a position in Beam Therapeutics in Q2 2022 and held it in 13 quarters.
  • Blue Trust Inc's Beam Therapeutics position peaked at $73.5K in Q3 2024.
  • 247 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.

Based on Blue Trust Inc's 13F filing for Q4 2025, filed 16 Jan 2026.